The protein-tyrosine phosphatase, Src homology-2 domain containing protein tyrosine phosphatase-2, is a crucial mediator of exogenous insulin-like growth factor signaling to human trophoblast

Endocrinology

Volumn 150, Issue 10, 2009, Pages 4744-4754

  Forbes, Karen ^a   West, Gemma ^a   Garside, Rebecca ^a   Aplin, John D ^a   Westwood, Melissa ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 2; SMALL INTERFERING RNA; SOMATOMEDIN;

ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; CHORIOCARCINOMA; CONTROLLED STUDY; CYTOTROPHOBLAST; ENZYME ACTIVATION; EXPLANT; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SPACE; MEDIATOR; PLACENTA; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; PROTEIN TYROSINE PHOSPHATASES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SOMATOMEDINS; TROPHOBLASTS;

EID: 70349326302     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0166     Document Type: Article

References (46)

1. Huppertz B, Herrler A 2005 Regulation of proliferation and apoptosis during development of the preimplantation embryo and the placenta. Birth Defects Res C Embryo Today 75:249-261 (Pubitemid 43244615)
2. Arnholdt H, Meisel F, Fandrey K, Löhrs U 1991 Proliferation of villous trophoblast of the human placenta in normal and abnormal pregnancies. Virchows Arch B Cell Pathol Incl Mol Pathol 60:365-372
3. Chen CP, Bajoria R, Aplin JD 2002 Decreased vascularization and cell proliferation in placentas of intrauterine growth-restricted fetuses with abnormal umbilical artery flow velocity waveforms.AmJ Obstet Gynecol 187:764-769
4. Woods KA, Camacho-Hübner C, Savage MO, Clark AJ 1996 Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335:1363-1367 (Pubitemid 26360455)
5. Forbes K, WestwoodM2008 The IGF axis and placental function. A mini review. Horm Res 69:129-137
6. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72 (Pubitemid 23306021)
7. Baker J, Liu JP, Robertson EJ, Efstratiadis A 1993 Role of insulinlike growth factors in embryonic and postnatal growth. Cell 75: 73-82 (Pubitemid 23306022)
8. Constância M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, Stewart F, Kelsey G, Fowden A, Sibley C, ReikW2002 Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 417:945-948
9. Sibley CP, Coan PM, Ferguson-Smith AC, Dean W, Hughes J, Smith P, Reik W, Burton GJ, Fowden AL, Constância M 2004 Placental-specific insulin-like growth factor 2 (Igf2) regulates the diffusional exchange characteristics of the mouse placenta. Proc Natl Acad Sci USA 101:8204-8208 (Pubitemid 38698078)
10. Forbes K, Westwood M, Baker PN, Aplin JD 2008 Insulin-like growth factor I and II regulate the life cycle of trophoblast in the developing human placenta. Am J Physiol Cell Physiol 294:C1313-C1322
11. Ostman A, Böhmer FD 2001 Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases. Trends Cell Biol 11: 258-266 (Pubitemid 32441736)
12. Neel BG, Tonks NK 1997 Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Biol 9:193-204 (Pubitemid 27135987)
13. Chen B, Bronson RT, Klaman LD, Hampton TG, Wang JF, Green PJ, Magnuson T, Douglas PS, Morgan JP, Neel BG 2000 Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat Genet 24:296-299 (Pubitemid 30132202)
14. Qu CK, Shi ZQ, Shen R, Tsai FY, Orkin SH, Feng GS 1997 A deletion mutation in theSH2-Ndomain of Shp-2 severely suppresses hematopoietic cell development. Mol Cell Biol 17:5499-5507 (Pubitemid 27357646)
15. Saxton TM, Ciruna BG, Holmyard D, Kulkarni S, Harpal K, Rossant J, Pawson T 2000 The SH2 tyrosine phosphatase shp2 is required for mammalian limb development. Nat Genet 24:420-423 (Pubitemid 30187445)
16. Yang W, Klaman LD, Chen B, Araki T, Harada H, Thomas SM, George EL, NeelBG2006 An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival. Dev Cell 10:317-327
17. Wu CJ, O'Rourke DM, Feng GS, Johnson GR, Wang Q, Greene MI 2001 The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors. Oncogene 20:6018-6025 (Pubitemid 32955044)
18. Hayashi K, Shibata K, Morita T, Iwasaki K, Watanabe M, Sobue K 2004 Insulin receptor substrate-1/SHP-2 interaction, a phenotypedependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells. J Biol Chem 279:40807-40818 (Pubitemid 39287678)
19. Maile LA, ClemmonsDR2002 The αVβ3 integrin regulates insulinlike growth factor I (IGF-I) receptor phosphorylation by altering the rate of recruitment of the Src-homology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-I receptor. Endocrinology 143:4259-4264
20. Maile LA, Clemmons DR 2002 Regulation of insulin-like growth factor I receptor dephosphorylation by SHPS-1 and the tyrosine phosphatase SHP-2. J Biol Chem 277:8955-8960
21. Kim H, Hawley TS, Hawley RG, BaumannH1998 Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells. Mol Cell Biol 18:1525-1533
22. Blakesley VA, Kato H, Roberts Jr CT, LeRoithD1995 Mutation of a conserved amino acid residue (tryptophan 1173) in the tyrosine kinase domain of the IGF-I receptor abolishes autophosphorylation but does not eliminate biologic function. J Biol Chem 270:2764-2769
23. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss 3rd JF 1986 Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118: 1567-1582
24. Forbes K, Desforges M, Garside R, Aplin JD, Westwood M 2009 Methods for siRNA-mediated reduction of mRNA and protein expression in human placental explants, isolated primary cells and cell lines. Placenta 30:124-129
25. Lacey HA, Nolan T, Greenwood SL, Glazier JD, Sibley CP 2005 Gestational profile of Na+/H+ exchanger and Cl-/HCO3-anion exchanger mRNA expression in placenta using real-time QPCR. Placenta 26:93-98
26. Matthews LC, Taggart MJ, WestwoodM2005 Effect of cholesterol depletion on mitogenesis and survival: the role of caveolar and non-caveolar domains in insulin-like growth factor-mediated cellular function. Endocrinology 146:5463-5473
27. Norris K, Norris F, Kono DH, Vestergaard H, Pedersen O, Theofilopoulos AN, Møller NP 1997 Expression of protein-tyrosine phosphatases in the major insulin target tissues. FEBS Lett 415:243-248 (Pubitemid 27451941)
28. SchneiderH1996 Ontogenic changes in the nutritive function of the placenta. Placenta 17:15-26
29. Shi ZQ, Lu W, Feng GS 1998 The Shp-2 tyrosine phosphatase has opposite effects in mediating the activation of extracellular signal-regulated and c-Jun NH2-terminal mitogen-activated protein kinases. J Biol Chem 273:4904-4908 (Pubitemid 28108641)
30. Xiao S, Rose DW, Sasaoka T, Maegawa H, Burke Jr TR, Roller PP, Shoelson SE, OlefskyJM1994 Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J Biol Chem 269:21244-21248
31. Noguchi T, Matozaki T, Horita K, Fujioka Y, KasugaM1994 Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation. Mol Cell Biol 14: 6674-6682
32. Neel BG, Gu H, Pao L 2003 The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 28:284-293 (Pubitemid 36776291)
33. Lieskovska J, Ling Y, Badley-Clarke J, ClemmonsDR2006 The role of Src kinase in insulin-like growth factor-dependent mitogenic signaling in vascular smooth muscle cells. J Biol Chem 281:25041-25053
34. Simmons DG, Natale DR, Begay V, Hughes M, Leutz A, Cross JC 2008 Early patterning of the chorion leads to the trilaminar trophoblast cell structure in the placental labyrinth. Development 135: 2083-2091 (Pubitemid 352015143)
35. Maruo T, Murata K, Matsuo H, Samoto T, Mochizuki M 1995 Insulin-like growth factor-I as a local regulator of proliferation and differentiated function of the human trophoblast in early pregnancy. Early Pregnancy 1:54-61
36. Fang J, Furesz TC, Lurent RS, Smith CH, Fant ME 1997 Spatial polarization of insulin-like growth factor receptors on the human syncytiotrophoblast. Pediatr Res 41:258-265 (Pubitemid 27066353)
37. Myers Jr MG, Mendez R, Shi P, Pierce JH, Rhoads R, White MF 1998 The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP-2 and negatively regulate insulin signaling. J Biol Chem 273:26908-26914 (Pubitemid 28471711)
38. Soloaga A, Thomson S, Wiggin GR, Rampersaud N, Dyson MH, Hazzalin CA, Mahadevan LC, Arthur JS 2003 MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14. EMBO J 22:2788-2797 (Pubitemid 36712374)
39. Deak M, Clifton AD, Lucocq LM, Alessi DR 1998 Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J 17:4426-4441 (Pubitemid 28362632)
40. Pierrat B, Correia JS, Mary JL, Tomás-Zuber M, LesslauerW1998 RSK-B, a novel ribosomal S6 kinase family member, is a CREB kinase under dominant control of p38α mitogen-activated protein kinase (p38αMAPK). J Biol Chem 273:29661-29671
41. Matalon ST, Drucker L, Fishman A, Ornoy A, LishnerM2008 The role of heat shock protein 27 in extravillous trophoblast differentiation. J Cell Biochem 103:719-729
42. Vargas A, Moreau J, Le Bellego F, Lafond J, Barbeau B 2008 Induction of trophoblast cell fusion by a protein tyrosine phosphatase inhibitor. Placenta 29:170-174
43. Zito CI, Qin H, Blenis J, Bennett AM 2007 SHP-2 regulates cell growth by controlling the mTOR/S6 kinase 1 pathway. J Biol Chem 282:6946-6953 (Pubitemid 47093675)
44. Borgatti P, Martelli AM, Bellacosa A, Casto R, Massari L, Capitani S, Neri LM 2000 Translocation of Akt/PKB to the nucleus of osteoblast- like MC3T3-E1 cells exposed to proliferative growth factors. FEBS Lett 477:27-32 (Pubitemid 30438852)
45. Missiroli S, Etro D, Buontempo F, Ye K, Capitani S, Neri LM 2009 Nuclear translocation of active AKT is required for erythroid differentiation in erythropoietin treated K562 erythroleukemia cells. Int J Biochem Cell Biol 41:570-577
46. Klammt J, Pfaffle R, Werner H, KiessW2008 IGF signaling defects as causes of growth failure and IUGR. Trends Endocrinol Metab 19:197-205